2014-2026 Global Antibody Drugs Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region
SKU ID : Maia-14931834 | Publishing Date : 26-Nov-2019 | No. of pages : 129
The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in
Major Region
s, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.Major Companies Covered
Seattle Genetics Inc.
Takeda Pharmaceutical U.S.A. Inc.
Abbott Laboratories
Spectrum Pharmaceuticals
Bristol-Myers Squibb
Alexion Pharmaceuticals
Johnson & Johnson
Adaltis S.r.l.
Ortho-Clinical Diagnostics.
Hoffman-La Roche
Wuhan Institute of Biological Products
Amgen
Merck & Co.
DiaSorin S.p.A. UK Branch
UCB Company
Dominion Biologicals Limited
Glaxosmithkline
Shanghai Rongsheng
Eli Lilly And Co.
Novartis
Beijing Baitai Pharma
Biogen Idec
Major Types Covered
Fully human antibodies
Humanized antibody
Murine
Chimeric antibodies
Major Applications Covered
Cancer Treatment
Autoimmune diseases
Organ Transplantation
Others
Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
…
Years considered for this report:
Historical Years:
2014-2018Base Year:
2019Estimated Year:
2019Forecast Period:
2019-2026Frequently Asked Questions
- By product type
- By End User/Applications
- By Technology
- By Region